Premium
MEASLES VACCINATION
Author(s) -
NORRBY ERLING,
LAGERCRANTZ RUTGER,
GARD SVEN
Publication year - 1969
Publication title -
acta pædiatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.1969.tb04715.x
Subject(s) - medicine , titer , measles , vaccination , measles virus , measles vaccine , antibody titer , adjuvant , antibody , virus , antibody response , immunology , immunization , virology
Summary Children immunized with 4 doses of formalin‐killed (FK) whole virus vaccine containing adjuvant and aqueous, purified hemagglutinin prepared from Tween‐ether (TE) treated material in different combinations have been followed serologically and clinically during a period of 3 to 4 years after the last dose of vaccine. The average decline in HI antibody titers was about 10‐fold during this period of time, except in children who had received 4 doses of TE vaccine. The latter group displayed about a 40‐fold decrease in titers. Four out of 10 children exposed to cases of regular measles displayed clinical symptoms of varying degrees of severity. Two more children responded with a rise in HI antibody titer only. All these reactions occurred in children with a pre‐exposure HI serum titer of 160 or higher. A case of pneumonia was encountered in connection with exposure to wild virus in a child who had received only 2 doses of FK vaccine.